Andriawan, N. A. (2023). Pembrolizumab as A Therapy for Triple-Negative Breast Cancer : Systematic Review. Journal of Herbal, Clinical and Pharmaceutical Science (HERCLIPS), 5(01), 58–67. https://doi.org/10.30587/herclips.v5i01.6285